JESSE STAFFORD: Open Payments
NPI 1316338361 · DECATUR, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 73 payments from 13 companies in 2025. Trend: 2023 $1,378 · 2024 $814 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $380 |
| Amgen Inc. | 19 | $210 |
| CVRx, Inc. | 2 | $208 |
| Edwards Lifesciences Corporation | 1 | $128 |
| Medtronic, Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| PFIZER INC. | 4 | $64 |
| Novo Nordisk Inc | 2 | $44 |
| Abbott Laboratories | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: LEQVIO, Repatha, Barostim Neo System, SAPIEN 3 Ultra RESILIA, COREVALVE EVOLUT R, ELIQUIS, VYNDAQEL, ENTRESTO.
Industry payments across AR — which companies pay providers there.
